APA (7th ed.) Citation

Wang, S., Wu, C., Li, X., Zhou, Y., Zhang, Q., Ma, F., . . . Guo, P. (2017). Syringaresinol-4-O-β-d-glucoside alters lipid and glucose metabolism in HepG2 cells and C2C12 myotubes. Elsevier.

Chicago Style (17th ed.) Citation

Wang, Shuai, Chongming Wu, Xin Li, Yue Zhou, Quanyang Zhang, Fuchao Ma, Jianhe Wei, Xiaopo Zhang, and Peng Guo. Syringaresinol-4-O-β-d-glucoside Alters Lipid and Glucose Metabolism in HepG2 Cells and C2C12 Myotubes. Elsevier, 2017.

MLA (9th ed.) Citation

Wang, Shuai, et al. Syringaresinol-4-O-β-d-glucoside Alters Lipid and Glucose Metabolism in HepG2 Cells and C2C12 Myotubes. Elsevier, 2017.